Patent ID: 6231536
Filing Date: 2001-05-15
Classification: A61K,A61M,A61N,A61P,B01D

Abstract:
A method for inducing an immune response against transformed, infected or diseased tissue in a patient comprisingremoving soluble cytokine receptor molecules selected from the group consisting of soluble tissue necrosis factor receptor-1 (""sTNFR-1""), soluble tissue necrosis factor receptor-2 (""sTNFR-2""), soluble interleukin-2 receptor (""sIL-2R""), soluble interleukin-1 receptor (""sIL-1R""), soluble interleukin-6 receptor (""sIL-6R""), and soluble interferon-gamma receptor (""sIFN-gammaR"") in the blood of the patient having a molecular weight of 120,000 daltons or less, until the transformed, infected, or diseased tissue is reduced in amount.